Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : RETA source : Www.globenewswire.com save search
Biogen Completes Acquisition of Reata Pharmaceuticals
Published: 2023-09-26 (Crawled : 13:00) - globenewswire.com
BIIB | $201.99 4.56% 4.32% 2.7M
|
Health Technology
|
| O: -0.02%
H: 1.37%
C: 1.21%
acquisition pharmaceuticals
Biogen to Acquire Reata Pharmaceuticals
Published: 2023-07-28 (Crawled : 11:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 51.72%
H: 1.55%
C: 1.52%
BIIB | $201.99 4.56% 4.32% 2.7M
|
Health Technology
|
| O: 0.19%
H: 1.88%
C: 0.73%
pharmaceuticals acquire
WPD Pharmaceuticals’ Licensor Receives FDA Fast Track Designation for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme; WPD Poland Arranges Loans
Published: 2021-07-12 (Crawled : 12:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 1.09%
H: 0.94%
C: -2.48%
MBRX | $4.35 -5.44% 3.37% 7.4K
|
Health Technology
|
| O: 5.28%
H: 0.0%
C: -0.56%
CNSP | News | $0.214 1.91% -4.9% 75K
|
Health Technology
|
| O: 7.18%
H: 2.06%
C: 2.06%
berubicin treatment fda fda fast track fast track fast track designation designation glioblastoma
Reata Pharmaceuticals Announces Participation in The Goldman Sachs 42nd Annual Global Healthcare Conference
Published: 2021-06-07 (Crawled : 18:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.16%
H: 5.64%
C: 2.4%
conference
Reata Announces that The FDA Has Asked The Company to Request a Pre-NDA Meeting for Omaveloxolone for the Treatment of Friedreich’s Ataxia
Published: 2021-05-19 (Crawled : 11:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 13.45%
H: 9.49%
C: 9.11%
treatment fda friedreich's ataxia friedreich’s ataxia
Reata Pharmaceuticals, Inc. Announces First Quarter 2021 Financial Results and Provides an Update on Clinical Development Programs
Published: 2021-05-06 (Crawled : 11:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.68%
H: 2.47%
C: 1.81%
financial results results
Reata Pharmaceuticals Announces Presentations at Upcoming Investor Conferences
Published: 2021-05-03 (Crawled : 11:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.33%
H: 0.45%
C: -1.55%
presentation conference
Reata Pharmaceuticals, Inc. To Report First Quarter 2021 Financials and To Provide an Update on Development Programs on May 6, 2021
Published: 2021-04-28 (Crawled : 22:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.11%
H: 0.11%
C: -2.58%
WPD Pharmaceuticals to Attend the 10th Congress of the Polish Society of Pediatric Oncology and Hematology and Present Assumption of the Phase 1 Study with Berubicin in Pediatric Malignant Gliomas
Published: 2021-04-27 (Crawled : 12:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 3.93%
H: 5.77%
C: -0.87%
MBRX | $4.35 -5.44% 3.37% 7.4K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: -1.88%
CNSP | News | $0.214 1.91% -4.9% 75K
|
Health Technology
|
| O: 0.96%
H: 1.43%
C: -3.33%
berubicin phase 1 phase 3 phase 2
Reata Announces FDA Accepted for Filing the NDA for Bardoxolone for the Treatment of Patients With Chronic Kidney Disease Caused by Alport Syndrome
Published: 2021-04-26 (Crawled : 21:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 3.93%
H: 5.77%
C: -0.87%
disease treatment fda fda acceptance kidney syndros
Reata Announces the Appointments of Christy J. Oliger and Shamim Ruff to Its Board of Directors
Published: 2021-04-15 (Crawled : 11:00) - globenewswire.com
ABT | News | $106.89 -0.65% -0.09% 4.2M
|
Health Technology
|
| O: 0.74%
H: 1.86%
C: 1.26%
STOK | $11.66 3.64% 3.35% 1.5M
|
Health Technology
|
| O: 1.66%
H: 0.06%
C: -5.65%
SRPT | $124.25 6.09% 5.75% 1.5M
|
Health Technology
|
| O: 0.61%
H: 2.56%
C: -1.69%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.76%
H: 0.61%
C: 0.14%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 1.17%
H: 3.5%
C: 1.54%
KPTI | $1.09 0.91% 1.2M
|
Health Technology
|
| O: 0.39%
H: 1.37%
C: -5.37%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: 1.81%
H: 1.08%
C: 0.18%
AMGN | News | $273.01 -0.19% -0.17% 1.5M
|
Health Technology
|
| O: 0.59%
H: 2.35%
C: 1.6%
Reata Pharmaceuticals, Inc. Submits NDA for Company’s Lead Program: Bardoxolone in Alport Syndrome
Published: 2021-03-01 (Crawled : 12:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.61%
H: 7.06%
C: 2.95%
syndros program
Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results and Provides an Update on Clinical Development Programs
Published: 2021-03-01 (Crawled : 12:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.61%
H: 7.06%
C: 2.95%
financial results results
Reata Pharmaceuticals, Inc. to Report Fourth Quarter and Full Year 2020 Financials and to Provide an Update on Development Programs on March 1, 2021
Published: 2021-02-22 (Crawled : 12:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.22%
H: 0.75%
C: -6.57%
Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Offering
Published: 2020-12-04 (Crawled : 18:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.53%
H: 4.05%
C: 1.55%
offering
Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Offering
Published: 2020-12-02 (Crawled : 03:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -9.74%
H: 1.78%
C: -0.4%
offering
Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock
Published: 2020-12-01 (Crawled : 21:05) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -9.74%
H: 1.78%
C: -0.4%
offering
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.